{
"main_header": {
"sid": 1282152,
"name": "Caribou Biosciences, Inc.",
"stock_name": "Caribou Biosciences, Inc.",
"full_name": "Caribou Biosciences, Inc.",
"name_url": "stocks-analysis/caribou-biosciences-inc",
"exchange": 210,
"exchangecode": "NAS",
"country_id": 2,
"currency": "USD",
"cmp": "1.68",
"chg": 0.05,
"chgp": "3.07%",
"dir": 1,
"prev_price": "1.63",
"mcapval": "168.55",
"mcap": "Micro Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 2320,
"indexname": "S&P 500",
"isin": "US1420381089",
"curr_date": "Dec 19",
"curr_time": "",
"bse_nse_vol": "3.73 M",
"exc_status": "Active",
"traded_date": "Dec 19, 2025",
"traded_date_str": "2025 12 19",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-registerF-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caribou-biosciences-inc-1282152-210&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Caribou Biosciences Hits New 52-Week High at $3.54",
"link": "https://www.marketsmojo.com/news/stocks-in-action/caribou-biosciences-hits-new-52-week-high-at-354-3671505",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CaribouBioscien_priceRelatedfactors_3671505.png",
"date": "2025-11-04 17:55:37",
"description": "Caribou Biosciences, Inc. has achieved a new 52-week high of USD 3.54, significantly up from its low of USD 0.66, reflecting a strong performance over the past year. With a market cap of USD 169 million, the company faces challenges in a competitive biotechnology sector."
}
],
"total": 5,
"sid": "1282152",
"stock_news_url": "https://www.marketsmojo.com/news/caribou-biosciences-inc-1282152"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}
Caribou Biosciences Hits New 52-Week High at $3.54
2025-11-04 17:55:37Caribou Biosciences, Inc. has achieved a new 52-week high of USD 3.54, significantly up from its low of USD 0.66, reflecting a strong performance over the past year. With a market cap of USD 169 million, the company faces challenges in a competitive biotechnology sector.
Read MoreNo announcement available
Corporate Actions
No corporate action available
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."






